Rhenman & Partners Asset Management’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $41K | Hold |
|
|||||
|
2017
Q1 | $85K | Hold |
|
|||||
|
2016
Q4 | $130K | Sell |
|
|||||
|
2016
Q3 | $945K | Hold |
|
|||||
|
2016
Q2 | $927K | Sell |
|
|||||
|
2016
Q1 | $1.57M | Buy |
|
|||||
|
2015
Q4 | $1.16M | Hold |
|
|||||
|
2015
Q3 | $1.52M | Sell |
|
|||||
|
2015
Q2 | $5.34M | Sell |
|
|||||
|
2015
Q1 | $3.13M | Buy |
|
|||||
|
2014
Q4 | $632K | Hold |
|
|||||
|
2014
Q3 | $768K | Buy |
|
|||||
|
2014
Q2 | $1.02M | Buy |
|
|||||
|
2014
Q1 | $395K | Sell |
|
|||||
|
2013
Q4 | $366K | Buy |
|